MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,313,095 | -20.2% | 440,380 | +26.2% | 0.01% | -14.3% |
| Q2 2023 | $80,628,863 | -36.6% | 349,043 | -33.5% | 0.01% | +16.7% |
| Q1 2023 | $127,158,884 | +120.7% | 524,886 | +164.4% | 0.01% | 0.0% |
| Q4 2022 | $57,611,723 | +441.3% | 198,490 | +21.2% | 0.01% | +500.0% |
| Q3 2022 | $10,644,000 | -9.1% | 163,774 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $11,711,000 | -27.3% | 163,614 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $16,103,000 | +14.1% | 164,119 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $14,113,000 | +6.2% | 166,540 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $13,288,000 | -18.1% | 166,540 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,223,000 | -22.4% | 166,540 | -6.8% | 0.00% | -50.0% |
| Q1 2021 | $20,896,000 | +86.7% | 178,640 | +77.5% | 0.00% | +100.0% |
| Q4 2020 | $11,191,000 | +175.3% | 100,662 | +194.0% | 0.00% | – |
| Q3 2020 | $4,065,000 | +4.8% | 34,241 | 0.0% | 0.00% | – |
| Q2 2020 | $3,878,000 | +69.6% | 34,241 | 0.0% | 0.00% | – |
| Q1 2020 | $2,286,000 | -26.7% | 34,241 | 0.0% | 0.00% | – |
| Q4 2019 | $3,120,000 | +5.7% | 34,241 | 0.0% | 0.00% | – |
| Q3 2019 | $2,952,000 | -17.7% | 34,241 | 0.0% | 0.00% | – |
| Q2 2019 | $3,589,000 | -16.3% | 34,241 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $4,289,000 | +11.1% | 34,241 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,860,000 | -66.0% | 34,241 | -35.4% | 0.00% | 0.0% |
| Q3 2018 | $11,344,000 | -36.2% | 52,980 | -16.7% | 0.00% | -50.0% |
| Q2 2018 | $17,781,000 | -31.1% | 63,574 | -71.2% | 0.00% | -33.3% |
| Q1 2018 | $25,791,000 | -60.8% | 220,831 | -69.2% | 0.00% | -62.5% |
| Q4 2017 | $65,825,000 | +164.4% | 717,125 | +29.5% | 0.01% | +166.7% |
| Q3 2017 | $24,900,000 | – | 553,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |